Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells

Atherosclerosis

Volumn 214, Issue 2, 2011, Pages 331-337

  Pirillo, Angela ^a   Reduzzi, Alice ^a   Ferri, Nicola ^a   Kuhn, Hartmut ^b   Corsini, Alberto ^a   Catapano, Alberico L ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c IRCCS MULTIMEDICA   (Italy)

Author keywords

15 Lipoxygenase; Endothelial cells; ICAM 1; LDL; LOX 1

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; CELL ADHESION MOLECULE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LIGAND; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOGEN ACTIVATED PROTEIN KINASE P38; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1;

ARTICLE; CELL LINE; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; UPREGULATION;

ANIMALS; ARACHIDONATE 15-LIPOXYGENASE; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LIGANDS; LIPOPROTEINS, LDL; NF-KAPPA B; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RABBITS; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS E; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 79151474344     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.11.006     Document Type: Article

References (40)

1. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004, 84:1381-1478.
2. Boullier A., Bird D.A., Chang M.K., et al. Scavenger receptors, oxidized LDL, and atherosclerosis. Ann N Y Acad Sci 2001, 947:214-222. [discussion 22-3].
3. Sakurai K., Sawamura T. Stress and vascular responses: endothelial dysfunction via lectin-like oxidized low-density lipoprotein receptor-1: close relationships with oxidative stress. J Pharmacol Sci 2003, 91:182-186.
4. Kataoka H., Kume N., Miyamoto S., et al. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 1999, 99:3110-3117.
5. Kume N., Kita T. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in atherogenesis. Trends Cardiovasc Med 2001, 11:22-25.
6. Vohra R.S., Murphy J.E., Walker J.H., Ponnambalam S., Homer-Vanniasinkam S. Atherosclerosis and the Lectin-like OXidized low-density lipoprotein scavenger receptor. Trends Cardiovasc Med 2006, 16:60-64.
7. Chen M., Kakutani M., Minami M., et al. Increased expression of lectin-like oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 2000, 20:1107-1115.
8. Nagase M., Hirose S., Sawamura T., Masaki T., Fujita T. Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats. Biochem Biophys Res Commun 1997, 237:496-498.
9. Chen M., Nagase M., Fujita T., et al. Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothelium: possible role of LOX-1 ligand and AGE. Biochem Biophys Res Commun 2001, 287:962-968.
10. Li D., Mehta J.L. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation 2000, 101:2889-2895.
11. Hoshikawa H., Sawamura T., Kakutani M., et al. High affinity binding of oxidized LDL to mouse lectin-like oxidized LDL receptor (LOX-1). Biochem Biophys Res Commun 1998, 245:841-846.
12. Aoyama T., Fujiwara H., Masaki T., Sawamura T. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells. J Mol Cell Cardiol 1999, 31:2101-2114.
13. Yla-Herttuala S., Rosenfeld M.E., Parthasarathy S., et al. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci U S A 1990, 87:6959-6963.
14. Yla-Herttuala S., Rosenfeld M.E., Parthasarathy S., et al. Gene expression in macrophage-rich human atherosclerotic lesions 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest 1991, 87:1146-1152.
15. Harats D., Shaish A., George J., et al. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2000, 20:2100-2105.
16. Huo Y., Zhao L., Hyman M.C., et al. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004, 110:2024-2031.
17. Bocan T.M., Rosebury W.S., Mueller S.B., et al. A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit. Atherosclerosis 1998, 136:203-216.
18. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973, 52:2745-2756.
19. Edgell C.J., McDonald C.C., Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A 1983, 80:3734-3737.
20. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955, 34:1345-1353.
21. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
22. Cominacini L., Pasini A.F., Garbin U., et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 2000, 275:12633-12638.
23. Schuh J., Fairclough G.F., Haschemeyer R.H. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc Natl Acad Sci U S A 1978, 75:3173-3177.
24. Norata G.D., Tibolla G., Seccomandi P.M., Poletti A., Catapano A.L. Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells. J Clin Endocrinol Metab 2006, 91:546-554.
25. Pirillo A., Uboldi P., Bolego C., Kuhn H., Catapano A.L. The 15-lipoxygenase-modified high density lipoproteins 3 fail to inhibit the TNF-alpha-induced inflammatory response in human endothelial cells. J Immunol 2008, 181:2821-2830.
26. Garton K.J., Ferri N., Raines E.W. Efficient expression of exogenous genes in primary vascular cells using IRES-based retroviral vectors. Biotechniques 2002, 32:830. 2, 4 passim.
27. Mehta J.L., Li D.Y. Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun 1998, 248:511-514.
28. Berliner J.A., Territo M.C., Sevanian A., et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990, 85:1260-1266.
29. Hofnagel O., Luechtenborg B., Weissen-Plenz G., Robenek H. Statins and foam cell formation: impact on LDL oxidation and uptake of oxidized lipoproteins via scavenger receptors. Biochim Biophys Acta 2007, 1771:1117-1124.
30. Weber C., Erl W., Pietsch A., et al. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb 1994, 14:1665-1673.
31. Quinn M.T., Parthasarathy S., Fong L.G., Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A 1987, 84:2995-2998.
32. Blair A., Shaul P.W., Yuhanna I.S., Conrad P.A., Smart E.J. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem 1999, 274:32512-32519.
33. Sawamura T., Kume N., Aoyama T., et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997, 386:73-77.
34. Navarra T., Del Turco S., Berti S., Basta G. The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: cardiovascular implications. J Atheroscler Thromb 2009.
35. Sigal E., Laughton C.W., Mulkins M.A. Oxidation, lipoxygenase, and atherogenesis. Ann N Y Acad Sci 1994, 714:211-224.
36. Feinmark S.J., Cornicelli J.A. Is there a role for 15-lipoxygenase in atherogenesis?. Biochem Pharmacol 1997, 54:953-959.
37. Funk C.D., Cyrus T. 12/15-lipoxygenase, oxidative modification of LDL and atherogenesis. Trends Cardiovasc Med 2001, 11:116-124.
38. Pirillo A., Uboldi P., Kuhn H., Catapano A.L. 15-Lipoxygenase-mediated modification of high-density lipoproteins impairs SR-BI- and ABCA1-dependent cholesterol efflux from macrophages. Biochim Biophys Acta 2006, 1761:292-300.
39. Dunn S., Vohra R.S., Murphy J.E., et al. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J 2008, 409:349-355.
40. Aoyama T., Sawamura T., Furutani Y., et al. Structure chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene. Biochem J 1999, 339(Pt 1):177-184.